Gustafsson, Johan http://orcid.org/0000-0002-1022-8370
Larsson, Erik
Ljungberg, Michael
Sjögreen Gleisner, Katarina
Funding for this research was provided by:
Fru Berta Kamprads Stiftelse (FBKS-2020-13)
Cancerfonden (21 1754 Pj 01H, FBKS-2019-44)
Lund University
Article History
Received: 15 February 2024
Accepted: 5 July 2024
First Online: 15 July 2024
Declarations
:
: Not applicable
: Not applicable
: KSG is acting as consultant for Immedica Pharma AB, Sweden, not related to this manuscript.